Scot Harper
Chief Tech/Sci/R&D Officer at RADIOPHARM THERANOSTICS LIMITED
Scot Harper active positions
Companies | Position | Start | End |
---|---|---|---|
RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 01/12/2021 | - |
Career history of Scot Harper
Former positions of Scot Harper
Companies | Position | Start | End |
---|---|---|---|
ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 07/05/2013 | 28/10/2016 |
Corporate Officer/Principal | 07/05/2013 | 14/05/2014 |
Training of Scot Harper
University of South Alabama | Graduate Degree |
DePauw University | Undergraduate Degree |
The Indiana University School of Medicine | Doctorate Degree |
Statistics
International
United States | 5 |
Australia | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
RADIOPHARM THERANOSTICS LIMITED | Health Services |
Private companies | 1 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Stock Market
- Insiders
- Scot Harper
- Experience